Advances In Treating Migraine in Your OB/GYN Practice: Navigating Treatment Paradigms to Improve Patient Care
November 8, 2022
November 8, 2023
Scroll to the Bottom of this Information to Begin this Course
This activity is provided by Physicians’ Education Resource®, LLC.
This activity is supported by an educational grant from Biohaven.
- Physicians — maximum of 1.0 AMA PRA Category 1 Credits™
- Nurses — 1.0 Contact Hours
All other healthcare professionals completing this course will be issued a statement of participation.
This educational program is directed toward obstetrician-gynecologists. Nurses, primary care physicians, nurse practitioners, and physician assistants who treat women with migraine are also invited to participate.
This online educational activity is designed to provide expert interpretation of new and emerging options for the prevention of migraine, with a forward-looking perspective on how migraine management for women can impact clinical practice of obstetrics and gynecology. Migraine pathophysiology, mitigating progression from episodic to chronic migraine, and topline clinical trial data for new and emerging agents targeting the calcitonin gene-related peptide pathway are among key topics presented in a multimedia format, including a series of video interviews with an expert thought leader integrated into text-based elements.
- Upon successful completion of this activity, you should be better prepared to:
- Describe the association between the pathobiology of migraine and its clinical presentation
- Design therapeutic strategies that reduce the risk of chronic migraine
- Evaluate clinical trial safety and efficacy data for approved small molecule CGRP receptor antagonists and CGRP-monoclonal antibodies used to prevent or reduce migraine episodes
Lauren R. Natbony, MD
Medical Director, Integrative Headache Medicine of New York
Assistant Clinical Professor of Neurology, Headache & Facial Pain
Icahn School of Medicine at Mount Sinai
New York, NY
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hours.
Faculty, Staff, and Planners’ Disclosures
The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible entities.
Lauren R. Natbony, MD, has no relevant financial relationships with ineligible companies.
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Instructions for Participation and Credit
- Complete the activity (including pre- and post-activity assessments).
- Answer the evaluation questions.
- Request credit using the drop-down menu.
Course Viewing Requirements
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.